The National Swine Health Strategy turns research into slat-level solutions. Learn how industry-wide alignment is tackling ...
A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) is due to the response of T cells against the disease, rather than the ...
A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) is due to the response of T cells against the disease, rather than the ...
A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) is due to the response of T cells against the disease, rather than the ...
Increased soybean meal concentrations in the diet may help alleviate the effects of PRRSV in infected weanling pigs. PRRSV infected pigs fed high soybean meal concentrations had a more efficient virus ...
Tsukuba, Japan—While traditional drug discovery often relies on static crystal structures, many biologically important proteins, including the scavenger receptor CD163-SRCR5, contain flexible loop ...
UConn researchers have identified a novel small molecule for the development of preventative treatment for a serious and costly disease in pigs. Porcine reproductive and respiratory syndrome virus ...
Porcine reproductive and respiratory syndrome virus (PRRSV) continues to devastate the global swine industry, yet the structural basis of how small molecules block its entry into host cells remains ...
On April 30, the US Food and Drug Administration (FDA), approved the use of a gene-edited pig to confer resistance to Porcine Reproductive and Respiratory Syndrome (PRRS), a devastating swine disease.
Porcine reproductive and respiratory syndrome virus (PRRSV) is the most widespread disease in the swine industry. In sows, PRRSV causes reproductive problems during gestation, including abnormal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results